Healthy Participants Clinical Trial
Official title:
Relationship Among Manual Wheelchair Workload, Speed, Energy Expenditure, and Propulsion Mechanics
Verified date | February 2022 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The first purpose of this study is to characterize the relationship among propulsion workload, self-selected propulsion speed, and propulsion kinetics/kinematics. The second purpose is to assess the between days repeatability/reliability of the above outcomes. There are no hypothesis This is a repeated measures clinical trial. All participants will complete the following: 1) Acclimation to propelling a manual wheelchair on a wheelchair ergometer; 2) Graded exercise test on the wheelchair ergometer to 80% of age adjusted estimated maximal heart rate; and 3) N=20 one minute propulsion bouts on the wheelchair ergometer.
Status | Completed |
Enrollment | 11 |
Est. completion date | November 13, 2021 |
Est. primary completion date | November 13, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - age 18 years or older - cleared to participate in physical activity as determined by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) - self-reported ability to propel a manual wheelchair - not currently disabled Exclusion Criteria: - no additional exclusion criteria if otherwise eligible to participate |
Country | Name | City | State |
---|---|---|---|
United States | UAB/Lakeshore Research Colaborative Building | Homewood | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-Selected Speed (meters per second) | Average linear propulsion speed during each completed propulsion cycle (i.e. contact+recovery) averaged across all completed propulsion cycles in the specified time frame. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Primary | Average Rolling Resistance (Newtons) | Average rolling resistance during each completed propulsion cycle (i.e. contact+recovery) averaged across all completed propulsion cycles in the specified time frame. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Number of completed propulsion cycles used to generate the outcomes of interest | The number of complete propulsion cycles occurring in the specified time frame. A complete propulsion cycle is defined as beginning with the onset of contact with the pushrim and ending with the onset of contact of the next propulsion cycle. A propulsion cycle includes contact and recovery. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average resultant force (Newtons) | Average resultant force during the contact phase of each completed propulsion cycle averaged across all completed propulsion cycles in the specified time frame. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average rate of rise of resultant force (Newtons per second squared) | Average rate of rise of resultant force during the contact phase of each completed propulsion cycle averaged across all completed propulsion cycles in the specified time frame. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average push frequency (pushes per minute) | For the specified time frame, the total number of completed propulsion cycles divided by the time to complete all the propulsion cycles in seconds multiplied by 60 seconds. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average push length (Degrees) | The distance over which a propulsive torque is applied to the pushrim during the contact phase of each complete propulsion cycle averaged across all completed propulsion cycles in the specified time frame. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average propulsive torque (Newton meter) | Average propulsive torque during the contact phase of each completed propulsion cycle averaged across all completed propulsion cycles in the specified time frame. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average push power output (Watts) | Average power during the contact phase of each each completed propulsion cycle averaged across all completed propulsion cycles in the time frame of interest. Push power output represents the energy the person applies to the pushrim during the contact phase. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average total work per push (Joules) | Total work during the contact phase of each completed propulsion cycle averaged across all completed propulsion cycles in the time frame of interest. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Average external power output (Watts) | Average external power output during the entire propulsion cycle (i.e. contact and recovery) averaged across all completed propulsion cycles in the specified time frame. External power output represents the energy expended by the user-wheelchair system. | Seconds 20 to 40 of each 1 minute propulsion bout | |
Secondary | Frequency of each unique propulsion pattern | For each complete propulsion cycle during the specified time frame, the recovery pattern will be classified into one of 5 categories: semi-circular, arcing, single loop, double loop, or indeterminate. The number of cycles and overall percentage in each category will be reported. Overall percentage is defined as [number of cycles in a category/total number of cycles * 100]. | Seconds 20 to 40 of each 1 minute propulsion bout |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05445440 -
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
|
Phase 1 | |
Completed |
NCT03712540 -
An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants
|
Phase 1 | |
Completed |
NCT03649165 -
A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT05956002 -
A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants
|
Phase 1 | |
Completed |
NCT05539976 -
A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
|
||
Withdrawn |
NCT04558216 -
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
|
Phase 1 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT06097390 -
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
|
Phase 1 | |
Completed |
NCT05546151 -
A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent
|
Phase 1 | |
Completed |
NCT05056246 -
Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
|
Phase 1 | |
Completed |
NCT04390776 -
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
|
Phase 1 | |
Completed |
NCT05074459 -
A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
|
Phase 1 | |
Enrolling by invitation |
NCT06089109 -
Creating VIP Corps to Reduce Maternal Deaths
|
N/A | |
Completed |
NCT05996250 -
Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects
|
N/A | |
Completed |
NCT03278080 -
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1
|
N/A | |
Completed |
NCT05064800 -
PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT04471298 -
A Study of Qishenyiqi Dripping Pills in Healthy Participants
|
Phase 1 | |
Completed |
NCT04914936 -
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
|
Phase 1 | |
Completed |
NCT02563262 -
Human Neutral Body Posture in Weightlessness
|
N/A | |
Completed |
NCT02882386 -
Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements
|
N/A |